Medtronic is a medical technology company, offering innovative therapies to fulfill its mission of alleviating pain, restoring health and extending life. The Company has six main business units, which develop and manufacture devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down's syndrome, obesity, chronic pain, spinal disorders and diabetes.

Type
Public
HQ
Minneapolis, US
Founded
1949
Size (employees)
88,000 (est)
Medtronic was founded in 1949 and is headquartered in Minneapolis, US
Report incorrect company information

Key People/Management at Medtronic

Omar Ishrak

Omar Ishrak

Chairman and CEO
Richard E. Kuntz

Richard E. Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Carol Surface

Carol Surface

SVP and Chief Human Resources Officer

Medtronic Office Locations

Medtronic has an office in Dublin, Moscow, Beijing, Mumbai and in 50 other locations
Minneapolis, US (HQ)
710 Medtronic Parkway
Miami, US
Doral Corporate Centre II, 3750 NW 87th Avenue, Suite 700
Beijing, CN
Beijing Rep. Office Suite 1805-1812 E1 Tower Oriental Plaza, No.1 East Chang An Ave., Dong Cheng District
Mumbai, IN
#1241, Solitaire Corporate Park, Building 12, Ghatkopar Andheri Link Road, Andheri
Dublin, IE
20 Lower Hatch Street
Moscow, RU
Naberezhnaya Tower C, Presnenskaya Naberezhnaya,10
Show all (54)
Report incorrect company information

Medtronic Financials and Metrics

Medtronic Financials

Medtronic's revenue was reported to be $29.71 b in FY, 2017 which is a 3% increase from the previous period.
USD

Revenue (Q2, 2018)

7.05 t

Gross profit (Q2, 2018)

4.93 t

Gross profit margin (Q2, 2018), %

69.9%

Net income (Q2, 2018)

2.013 t

EBIT (Q2, 2018)

1.901 t

Market capitalization (5-Feb-2018)

113.8 b

Cash (4-Feb-2018)

5.5 b

EV

134.2 b
Medtronic's current market capitalization is $113.8 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Revenue

17 b20.3 b28.8 b29.7 b

Revenue growth, %

19%42%3%

Cost of goods sold

4.3 b6.3 b9.1 b9.3 b

Gross profit

12.7 b14 b19.7 b20.4 b
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Revenue

7.3 b7.1 b6.9 b7.2 b7.3 b7.28 t7.4 b7.05 t

Cost of goods sold

2.5 b2.2 b2.1 b2.3 b2.3 b2.27 t2.3 b2.12 t

Gross profit

4.8 b4.9 b4.8 b4.9 b5 b5.01 t5 b4.93 t

Gross profit Margin, %

66%69%69%68%68%69%68%70%
Annual
usdY, 2014FY, 2015FY, 2016FY, 2017

Cash

13.2 m4.8 b186.4 m5 b

Accounts Receivable

17.1 m

Inventories

1.7 b3.5 b3.5 b3.3 b

Current Assets

21.2 b30.8 b23.6 b24.9 b
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

46 k3 b2.4 b2.7 b3.1 b3 b2.8 b4.7 b5.5 b

Accounts Receivable

(68 m)

Inventories

3.4 b3.5 b3.5 b3.6 b3.7 b3.7 b3.5 b

Current Assets

46 k29.1 b28.7 b27.6 b23.5 b22.5 b22.4 b24.8 b25.2 b
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

3.1 b2.7 b3.5 b4 b

Depreciation and Amortization

349 m1.3 b2.8 b2 b

Inventories

(39 m)(282 m)(186 m)

Accounts Payable

(16.7 m)
Quarterly
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

Net Income

(37.1 m)820 m1.3 b2.4 b929 m2 b2.9 b1 b

Depreciation and Amortization

701 m1.4 b2.1 b737 m1.5 b2.2 b636 m

Inventories

(207 m)(326 m)(388 m)(101 m)(187 m)(261 m)

Accounts Payable

1.3 b1.4 b1.4 b
USDY, 2017

EV/CFO

182.1 x

Financial Leverage

1.8 x
Show all financial metrics

Medtronic Operating Metrics

Medtronic's Patients Served was reported to be 65 m in FY, 2016.
FY, 2014FY, 2015FY, 2016

Countries

160 160

Patents Issued

27 k53 k45 k

Patients Served

65 m
Show all operating metrics
Report incorrect company information